FredlawrenceHardwickeMD

I have been a medical oncologist with the Southwest Cancer Center at UMC since 2000.

Dr. Hardwicke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1001 US Highway 83 N
Childress, TX 79201
Phone+1 940-937-3636

Fax+1 940-937-9615

University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
Texas Tech University Health Sciences Center at LubbockResidency, Internal Medicine, 1985 - 1988
The University of Texas Health Science Center at San AntonioClass of 1985

PubMed

7 citations
Pure Squamous Cell Carcinoma of the Gallbladder Masquerading as a Hepatic Mass.
Abhilash Perisetti, Saikiran Raghavapuram, Benjamin Tharian, Irfan Warraich, Fred Hardwicke
Cureus. 2018-01-01
37 citations
Acute Cardiac Toxicity Associated with High‐Dose Intravenous Methotrexate Therapy: Case Report and Review of the Literature
Alejandro Perez-Verdia, Freddy Angulo, Fred L. Hardwicke, Kenneth Nugent
Pharmacotherapy. 2005-09-01
23 citations
Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Somedeb Ball, Avash Das, Wasawat Vutthikraivit, Peggy J Edwards, Fred Hardwicke
Clinical Lymphoma, Myeloma & Leukemia. 2020-02-01

Abstracts/Posters

Daratumumab-Related Hematological Toxicities in Patients with Multiple Myeloma: A Combined Analysis of Five Phase III Randomized Controlled Trials
Fred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Updated Meta-Analysis to Evaluate the Incidence of Atrial Fibrillation and Major Bleeding in Patients with Hematologic Malignancies Treated with Ibrutinib
Fred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Efficacy of Upfront Daratumumab Combination Regimen in Patients with Newly Diagnosed Multiple Myeloma
Fred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Updated Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Infection and Pneumonia in Patients with Multiple Myeloma Treated with Daratumumab
Fred Hardwicke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all